Cargando…

Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy

BACKGROUND: The epidemiology of myeloid hematologic malignancies in Italy has been poorly investigated. METHODS: We used a validated database of 1974-2003 incident cases of hematologic malignancies among the resident population (all ages) of Sardinia, Italy, to describe the incidence of myeloid mali...

Descripción completa

Detalles Bibliográficos
Autores principales: Broccia, Giorgio, Carter, Jonathan, Ozsin-Ozler, Cansu, De Matteis, Sara, Cocco, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605662/
https://www.ncbi.nlm.nih.gov/pubmed/37877513
http://dx.doi.org/10.1177/10732748231202906
_version_ 1785127131916795904
author Broccia, Giorgio
Carter, Jonathan
Ozsin-Ozler, Cansu
De Matteis, Sara
Cocco, Pierluigi
author_facet Broccia, Giorgio
Carter, Jonathan
Ozsin-Ozler, Cansu
De Matteis, Sara
Cocco, Pierluigi
author_sort Broccia, Giorgio
collection PubMed
description BACKGROUND: The epidemiology of myeloid hematologic malignancies in Italy has been poorly investigated. METHODS: We used a validated database of 1974-2003 incident cases of hematologic malignancies among the resident population (all ages) of Sardinia, Italy, to describe the incidence of myeloid malignancies overall (N = 4389 cases) and by subtype. We investigated the time trend of acute myeloid leukemia (N = 1227 cases), chronic myeloid leukemia (N = 613 cases), and myelodysplastic syndrome (N = 1296 cases), and used Bayesian methods to explore their geographic spread, and Poisson regression analysis to estimate their association with environmental and socio-economic factors. RESULTS: The annual standardized (world population) incidence rate (IR) of myeloid malignancies over the study period was 6.5 per 100,000 (95% CI 6.2-6.7). Myelodysplastic syndromes were the most prevalent subgroup (IR = 1.7, 95% CI 1.5-1.8). Incidence of all myeloid malignancies combined increased sharply during the study period with an annual percent change (APC) of 10.06% (95% CI 9.51-10.61), 19.77% for myelodysplastic syndromes (95% CI 19.63-19.91), and 3.18% (95% CI 2.99-3.37) for acute myeloid leukemia. Chronic myeloid leukemia did not show an upward trend. Apart from sporadic excesses in small rural communities and the major urban area, there was no evidence of spatial clustering. The risk of myeloid malignancies increased with increasing prevalence of sheep breeding. CONCLUSIONS: Our results might prompt further research on the local genetic and environmental determinants of myeloid hematologic malignancies.
format Online
Article
Text
id pubmed-10605662
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106056622023-10-28 Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy Broccia, Giorgio Carter, Jonathan Ozsin-Ozler, Cansu De Matteis, Sara Cocco, Pierluigi Cancer Control Original Research Article BACKGROUND: The epidemiology of myeloid hematologic malignancies in Italy has been poorly investigated. METHODS: We used a validated database of 1974-2003 incident cases of hematologic malignancies among the resident population (all ages) of Sardinia, Italy, to describe the incidence of myeloid malignancies overall (N = 4389 cases) and by subtype. We investigated the time trend of acute myeloid leukemia (N = 1227 cases), chronic myeloid leukemia (N = 613 cases), and myelodysplastic syndrome (N = 1296 cases), and used Bayesian methods to explore their geographic spread, and Poisson regression analysis to estimate their association with environmental and socio-economic factors. RESULTS: The annual standardized (world population) incidence rate (IR) of myeloid malignancies over the study period was 6.5 per 100,000 (95% CI 6.2-6.7). Myelodysplastic syndromes were the most prevalent subgroup (IR = 1.7, 95% CI 1.5-1.8). Incidence of all myeloid malignancies combined increased sharply during the study period with an annual percent change (APC) of 10.06% (95% CI 9.51-10.61), 19.77% for myelodysplastic syndromes (95% CI 19.63-19.91), and 3.18% (95% CI 2.99-3.37) for acute myeloid leukemia. Chronic myeloid leukemia did not show an upward trend. Apart from sporadic excesses in small rural communities and the major urban area, there was no evidence of spatial clustering. The risk of myeloid malignancies increased with increasing prevalence of sheep breeding. CONCLUSIONS: Our results might prompt further research on the local genetic and environmental determinants of myeloid hematologic malignancies. SAGE Publications 2023-10-25 /pmc/articles/PMC10605662/ /pubmed/37877513 http://dx.doi.org/10.1177/10732748231202906 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Broccia, Giorgio
Carter, Jonathan
Ozsin-Ozler, Cansu
De Matteis, Sara
Cocco, Pierluigi
Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
title Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
title_full Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
title_fullStr Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
title_full_unstemmed Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
title_short Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
title_sort incidence and bayesian mapping of myeloid hematologic malignancies in sardinia, italy
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605662/
https://www.ncbi.nlm.nih.gov/pubmed/37877513
http://dx.doi.org/10.1177/10732748231202906
work_keys_str_mv AT brocciagiorgio incidenceandbayesianmappingofmyeloidhematologicmalignanciesinsardiniaitaly
AT carterjonathan incidenceandbayesianmappingofmyeloidhematologicmalignanciesinsardiniaitaly
AT ozsinozlercansu incidenceandbayesianmappingofmyeloidhematologicmalignanciesinsardiniaitaly
AT dematteissara incidenceandbayesianmappingofmyeloidhematologicmalignanciesinsardiniaitaly
AT coccopierluigi incidenceandbayesianmappingofmyeloidhematologicmalignanciesinsardiniaitaly